OSIMERTINIB

13013 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking OSIMERTINIB:

# Side effect Count
0 DEATH 4874
1 MALIGNANT NEOPLASM PROGRESSION 1654
2 DIARRHOEA 795
3 DRUG RESISTANCE 647
4 RASH 452
5 DECREASED APPETITE 412
6 INTERSTITIAL LUNG DISEASE 410
7 FATIGUE 395
8 DYSPNOEA 345
9 OFF LABEL USE 345
See all common reactions for OSIMERTINIB

OSIMERTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HER2 GENE AMPLIFICATION 5 0.5000
1 EGFR GENE MUTATION 87 0.3321
2 ACQUIRED GENE MUTATION 258 0.2983
3 BRAF V600E MUTATION POSITIVE 6 0.2222
4 MALIGNANT TRANSFORMATION 54 0.1782
5 ERYTHEMA DYSCHROMICUM PERSTANS 6 0.1765
6 NON-SMALL CELL LUNG CANCER RECURRENT 21 0.1694
7 RET GENE MUTATION 4 0.1667
8 BRAF GENE MUTATION 9 0.1406
9 METASTASES TO MENINGES 121 0.0894
See all enriched reactions for OSIMERTINIB